title: [Partial androgenic deficit in the aging male].
abstract: It is possible to observe in the aging male an hypotestosteronemia below 3 ng/ml. The indications of an androgenic treatment are discussed with their benefits, risks, contra-indications and choices of molecules. Testosterone-gel seems to be now the first choice for this type of patient. In case of normal testosteronemia and erectile dysfunction, the benefits/risks ratio of sildenafil is very favorable, except when contra-indicated.
authors.affiliation: Service d'Endocrinologie, Hôpital Erasme.
authors.forename: J
authors.initials: J
authors.lastname: Mockel
authors.forename: C
authors.initials: C
authors.lastname: Schulman
authors.forename: J
authors.initials: J
authors.lastname: Sternon
mesh_terms: D000368:Aged; D000375:Aging / Q000187:drug effects / Q000502:physiology*; D000075202:Contraindications; D007172:Erectile Dysfunction / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D018579:Patient Selection; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D013739:Testosterone / Q000097:blood / Q000172:deficiency* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D013739:Testosterone; D000068677:Sildenafil Citrate